Login / Signup

Squaramide Tethered Clindamycin, Chloroquine, and Mortiamide Hybrids: Design, Synthesis, and Antimalarial Activity.

Thomas TremblayCatherine BergeronDominic GagnonChristopher BérubéNormand VoyerDave RichardDenis Giguère
Published in: ACS medicinal chemistry letters (2023)
Malaria remains one of the major health problems in the world. In this work, a series of squaramide tethered chloroquine, clindamycin, and mortiamide D hybrids have been synthesized to assess their in vitro antiplasmodial activity against 3D7 (chloroquine-sensitive) and Dd2 strains of Plasmodium falciparum . The most active compound, a simple chloroquine analogue, displayed low nanomolar IC 50 value against both strains (3 nM for 3D7 strain and 18 nM for Dd2 strain). Moreover, all molecular hybrids incorporating the hydroxychloroquine scaffold showed the most potent activities, exemplified with a chloroquine dimer, IC 50 = 31 nM and 81 nM against 3D7 and Dd2 strains, respectively. These results highlight the first time use of clindamycin and mortiamide D as antimalarial molecular hybrids and establish these valuable hits for future optimization.
Keyphrases
  • plasmodium falciparum
  • photodynamic therapy
  • escherichia coli
  • mental health
  • healthcare
  • public health
  • single molecule
  • current status
  • health promotion
  • risk assessment
  • health information
  • tissue engineering